Prevention genes predispose breast and ovarian cancer genes brca2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Tumor Cells, Cultured Ovary Epithelial Cells Neoplastic Stem Cells MCF-7 Cells Cell Line Chromosomes, Human, Pair 17 Mammary Glands, Human

Organisms4

Mice, Nude Adenoviridae Mice, SCID Mice, Inbred BALB C

Diseases50

Ovarian Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Genetic Predisposition to Disease Neoplasms Carcinoma, Ductal, Breast Breast Diseases Cystadenocarcinoma, Serous Carcinoma Neoplasm Invasiveness Breast Neoplasms, Male Neoplasm Metastasis Prostatic Neoplasms Neoplastic Syndromes, Hereditary Lung Neoplasms Adenocarcinoma, Clear Cell Disease Progression Colonic Neoplasms Adenocarcinoma, Mucinous Carcinoma, Endometrioid Neoplasm Recurrence, Local Peritoneal Neoplasms Cell Transformation, Neoplastic Ascites Adenocarcinoma Stomach Neoplasms Pancreatic Neoplasms Fallopian Tube Neoplasms Fibrocystic Breast Disease Colorectal Neoplasms Mammary Neoplasms, Experimental Carcinoma, Intraductal, Noninfiltrating Endometrial Neoplasms Carcinoma, Lobular Cystadenocarcinoma Uterine Cervical Neoplasms Neovascularization, Pathologic Neoplasms, Hormone-Dependent Hereditary Breast and Ovarian Cancer Syndrome Carcinoma, Squamous Cell Disease Models, Animal Gliosarcoma Genital Neoplasms, Female Neoplasms, Second Primary Neoplasms, Cystic, Mucinous, and Serous Genomic Instability Neoplasms, Experimental Carcinoma in Situ Carcinogenesis Neoplasms, Multiple Primary

Chemicals and Drugs49

BRCA1 Protein BRCA2 Protein Neoplasm Proteins CA-125 Antigen Rad51 Recombinase Tumor Markers, Biological Transcription Factors Antineoplastic Agents Receptors, Estrogen Receptor, erbB-2 DNA, Neoplasm RNA, Messenger Cisplatin Receptors, Progesterone Paclitaxel RNA, Small Interfering Tamoxifen Tumor Suppressor Proteins Tumor Suppressor Protein p53 Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal DNA-Binding Proteins Carboplatin Nuclear Proteins Prodrugs RNA, Neoplasm Estrogens Epididymal Secretory Proteins Antigens, Neoplasm Cancer Vaccines Estrogen Receptor alpha Antibodies, Monoclonal MicroRNAs Taxoids Platinum Compounds DNA Primers Anticarcinogenic Agents Cyclophosphamide Proto-Oncogene Proteins Platinum Receptor, Epidermal Growth Factor Thymidine Kinase Protein-Serine-Threonine Kinases Antibodies, Monoclonal, Humanized Fluorouracil Genetic Markers Cell Cycle Proteins Contraceptives, Oral Ganciclovir

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Genetic Testing Genetic Therapy Prognosis Gene Expression Profiling Risk Factors Early Detection of Cancer Neoplasm Staging Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Survival Analysis Mammography DNA Mutational Analysis Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Risk Case-Control Studies Oligonucleotide Array Sequence Analysis Neoplasm Transplantation Survival Rate Risk Assessment Blotting, Western Follow-Up Studies Prospective Studies Disease-Free Survival Retrospective Studies Transfection Treatment Outcome Transplantation, Heterologous Incidence Mastectomy Sensitivity and Specificity Polymerase Chain Reaction Odds Ratio Cohort Studies Chemotherapy, Adjuvant Reproducibility of Results Gene Transfer Techniques Mammary Neoplasms, Experimental Registries Breast Self-Examination Multivariate Analysis Questionnaires Kaplan-Meier Estimate Tissue Array Analysis Combined Modality Therapy Logistic Models Breast Implants Pedigree Neoplasm Grading Predictive Value of Tests Salpingectomy Drug Screening Assays, Antitumor Tumor Burden Clinical Trials as Topic Models, Biological Drug Administration Schedule Confidence Intervals Cluster Analysis Immunoenzyme Techniques Disease Models, Animal SEER Program Mass Screening Gene Knockdown Techniques Flow Cytometry Ovariectomy Molecular Targeted Therapy Ultrasonography, Mammary Neoplasms, Experimental Mastectomy, Segmental

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes64

Genes, BRCA1 Genes, BRCA2 Germ-Line Mutation Genes, Neoplasm Mutation Genetic Predisposition to Disease Gene Expression Regulation, Neoplastic Heterozygote DNA Repair DNA Damage Drug Resistance, Neoplasm Breast Feeding Genetic Vectors Cell Proliferation Apoptosis Risk Genes, Tumor Suppressor DNA Methylation Promoter Regions, Genetic Transfection Signal Transduction Oncogenes Sensitivity and Specificity Time Factors Odds Ratio Genotype Cell Division Cell Cycle Genes, Transgenic, Suicide RNA Interference Gene Silencing Down-Regulation Genes, p53 Gene Expression Cell Survival Postmenopause Base Sequence Polymorphism, Genetic Founder Effect Dose-Response Relationship, Drug Cell Movement Loss of Heterozygosity Alleles Menopause Phenotype Up-Regulation Cell Growth Processes Exons Gene Amplification Premenopause Genome, Human Chromosomes, Human, Pair 17 Gene Regulatory Networks Algorithms Polymorphism, Single Nucleotide Genomic Instability Parity Genes, erbB-2 Phosphorylation Gene Dosage Transcription, Genetic Diet Genetic Markers Drug Synergism

Disciplines and Occupations5

Immunohistochemistry Genetic Counseling Genomics Medical Oncology Computational Biology

Anthropology, Education, Sociology and Social Phenomena2

Centers for Disease Control and Prevention (U.S.)National Cancer Institute (U.S.)

Information Science9

Survival Rate Incidence Registries Base Sequence Questionnaires Molecular Sequence Data SEER Program Algorithms Databases, Genetic

Named Groups2

Health Care36

Genetic Testing Risk Factors Primary Prevention Survival Analysis Risk Case-Control Studies Survival Rate Risk Assessment Follow-Up Studies Prospective Studies Disease-Free Survival Retrospective Studies Genetic Counseling Treatment Outcome Age Factors Incidence Sensitivity and Specificity Odds Ratio Cohort Studies Reproducibility of Results Registries Multivariate Analysis Questionnaires Kaplan-Meier Estimate Logistic Models Predictive Value of Tests Family Health Clinical Trials as Topic Secondary Prevention Centers for Disease Control and Prevention (U.S.)Confidence Intervals Cluster Analysis SEER Program Mass Screening Parity National Cancer Institute (U.S.)

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms BRCA1 Protein Genes, BRCA1 BRCA2 Protein Genes, BRCA2 Breast Breast Neoplasms Germ-Line Mutation Neoplasms, Glandular and Epithelial Genes, Neoplasm Neoplasm Proteins Mutation Cell Line, Tumor Genetic Predisposition to Disease Genetic Testing Gene Expression Regulation, Neoplastic Heterozygote Neoplasms Carcinoma, Ductal, Breast Genetic Therapy Breast Diseases Tumor Cells, Cultured CA-125 Antigen Cystadenocarcinoma, Serous Rad51 Recombinase Tumor Markers, Biological Mice, Nude Transcription Factors Carcinoma Antineoplastic Agents DNA Repair Neoplasm Invasiveness Prognosis Gene Expression Profiling DNA Damage Breast Neoplasms, Male Risk Factors Early Detection of Cancer Drug Resistance, Neoplasm Neoplasm Metastasis Receptors, Estrogen Neoplasm Staging Prostatic Neoplasms Adenoviridae Breast Feeding Receptor, erbB-2 Reverse Transcriptase Polymerase Chain Reaction Genetic Vectors Xenograft Model Antitumor Assays DNA, Neoplasm Primary Prevention Survival Analysis Mammography Cell Proliferation Neoplastic Syndromes, Hereditary Apoptosis DNA Mutational Analysis RNA, Messenger Cisplatin Antineoplastic Combined Chemotherapy Protocols Lung Neoplasms Immunohistochemistry Receptors, Progesterone Risk Case-Control Studies Adenocarcinoma, Clear Cell Oligonucleotide Array Sequence Analysis Genes, Tumor Suppressor Neoplasm Transplantation Paclitaxel Disease Progression Jews Colonic Neoplasms RNA, Small Interfering Survival Rate Tamoxifen Risk Assessment Blotting, Western Follow-Up Studies Adenocarcinoma, Mucinous Prospective Studies Carcinoma, Endometrioid Disease-Free Survival Tumor Suppressor Proteins Neoplasm Recurrence, Local United States Peritoneal Neoplasms Tumor Suppressor Protein p53 DNA Methylation Retrospective Studies Genetic Counseling Promoter Regions, Genetic Cell Transformation, Neoplastic Transfection Signal Transduction Treatment Outcome Transplantation, Heterologous Antineoplastic Agents, Phytogenic Age Factors Incidence

No FAQ available that match "prevention genes predispose breast and ovarian cancer genes brca2"